You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR DEXILANT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DEXILANT

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00251693 ↗	Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis	Completed	Takeda	Phase 3	2005-12-01	The purpose of this study is to assess the efficacy and safety of 8 weeks of once-daily (QD) treatment with dexlansoprazole modified release (MR) 60 mg or 90 mg or lansoprazole 30 mg in healing subjects with endoscopically proven erosive esophagitis.
NCT00251719 ↗	Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis	Completed	Takeda	Phase 3	2005-12-01	This is a study to assess the efficacy and safety of 8 weeks of treatment with Dexlansoprazole modified release (MR)(60 mg daily and 90 mg daily) compared to Lansoprazole (30 mg daily) in healing subjects with endoscopically proven erosive esophagitis.
NCT00251745 ↗	Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn	Completed	Takeda	Phase 3	2005-12-01	The purpose of this study is to assess the efficacy and safety of daily treatment with Dexlansoprazole modified release (MR) (60 mg or 90 mg once daily [QD]) compared to placebo QD in relief of daytime and nighttime heartburn over 4 weeks in subjects with gastroesophageal reflux disease (GERD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DEXILANT

Condition Name

Chart
Table

Condition Name for DEXILANT
Intervention	Trials
Gastroesophageal Reflux Disease	7
Esophagitis, Peptic	5
Esophagitis, Reflux	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DEXILANT
Intervention	Trials
Gastroesophageal Reflux	17
Esophagitis, Peptic	15
Esophagitis	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DEXILANT

Trials by Country

Map
Table

Trials by Country for DEXILANT
Location	Trials
United States	450
Mexico	14
Canada	12
India	9
Germany	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DEXILANT
Location	Trials
California	18
Illinois	17
Arizona	16
Texas	16
Ohio	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DEXILANT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DEXILANT
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	11
Phase 2	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DEXILANT
Clinical Trial Phase	Trials
Completed	21
Unknown status	2
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DEXILANT

Sponsor Name

Chart
Table

Sponsor Name for DEXILANT
Sponsor	Trials
Takeda	22
Vanderbilt University	2
Mayo Clinic	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DEXILANT
Sponsor	Trials
Industry	23
Other	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.